Engaging M-health for Symptom Monitoring and Health Promotion for Women on Endocrine Therapy for Breast Cancer (EmSHAPE)

The purpose of the study is to learn more about ways to help patients understand and manage side-effects from hormone therapy. The investigators will use the information from this study to design future studies to better understand how our well our tools work to help patients monitor and manage symptoms from hormone therapy and to stay on their hormone therapy for the recommended period of time.

NCT Number	NCT07454499
Lead Sponsor	Abramson Cancer Center at Penn Medicine Collaborators: Fox Chase Cancer Center, National Cancer Institute (NCI)
Conditions	Cancer
Enrollment	60 participants
Start Date	2026-05-13
Primary Completion	2027-11-30 (estimated)
Study Completion	2027-12-31 (estimated)
Updated on ClinicalTrials.gov	2026-06-12